Skip to content

Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry

The Pennsylvania Idiopathic Pulmonary Fibrosis State-wide Research Registry

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00540475
Acronym
PA-IPF
Enrollment
2000
Registered
2007-10-08
Start date
2007-09-30
Completion date
2018-07-31
Last updated
2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Pulmonary Fibrosis

Keywords

Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease

Brief summary

The Pennsylvania Idiopathic Pulmonary Fibrosis State-wide Research Registry (PA-IPF) is a cooperative project between five medical centers to coordinate a team of investigators. The aim of this registry will be: 1) To assess the extent of lung fibrosis in the commonwealth of Pennsylvania 2) To provide better access of patients with pulmonary fibrosis in all regions of Pennsylvania to standard of care and diagnosis 3) To facilitate the translation of new therapeutic interventions from the bench to the bedside.

Detailed description

The University of Pittsburgh Medical Center, Dorothy P. & Richard P. Simmons Center for Interstitial Lung Disease is the coordination center for the Pennsylvania Idiopathic Pulmonary Fibrosis Statewide Research Registry, the collaborative institutions include: the University of Pennsylvania Health System, Geisinger Health System, and Penn State Milton S. Hershey Medical Center. The PA-IPF Registry developed into a web site that contains information for patients, health professionals, and families, as well as an Internet-based database that will store information about patients to provide them with guidance about care, research, and support groups close to the area in which they live. Benefits for membership in the PA-IPF Registry include: * Staying informed about IPF research news, both nationally and locally. * Having advance notice of any IPF research in which patients may be eligible to participate.

Interventions

None listed

Sponsors

Temple University
CollaboratorOTHER
University of Pennsylvania
CollaboratorOTHER
Geisinger Clinic
CollaboratorOTHER
Milton S. Hershey Medical Center
CollaboratorOTHER
University of Pittsburgh
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* IPF diagnosis * Sufficient testing results completed for an IPF Diagnosis (screening script) * Adults (age \> 18 years old) * Participants who read and comprehend English language

Exclusion criteria

* Children * Prisoner-patients

Design outcomes

Primary

MeasureTime frameDescription
IPF Disease Course5 yearsMonitor IPF disease course

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026